- Home
- SGMT vs STRW Comparison
SGMT vs STRW Comparison
Compare SGMT & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGMT | STRW |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 192.0M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SGMT | STRW |
|---|---|---|
| Price | $8.98 | $14.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $26.13 | $13.88 |
| AVG Volume (30 Days) | ★ 1.0M | 42.9K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 5.17% |
| EPS Growth | N/A | ★ 5.26 |
| EPS | N/A | ★ 0.33 |
| Revenue | $2,000,000.00 | ★ $154,999,000.00 |
| Revenue This Year | N/A | $8.52 |
| Revenue Next Year | N/A | $3.95 |
| P/E Ratio | ★ N/A | $84.94 |
| Revenue Growth | N/A | ★ 32.41 |
| 52 Week Low | $4.50 | $10.08 |
| 52 Week High | $10.06 | $14.75 |
Technical Indicators
Market Signals| Indicator | SGMT | STRW |
|---|---|---|
| Relative Strength Index (RSI) | 68.49 | 59.99 |
| Support Level | $6.95 | $12.59 |
| Resistance Level | $8.84 | $14.75 |
| Average True Range (ATR) | 0.50 | 0.36 |
| MACD | 0.14 | -0.02 |
| Stochastic Oscillator | 90.51 | 68.37 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.